These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10543742)

  • 1. Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance.
    Burtnick MN; Woods DE
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2648-56. PubMed ID: 10543742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene.
    DeShazer D; Brett PJ; Carlyon R; Woods DE
    J Bacteriol; 1997 Apr; 179(7):2116-25. PubMed ID: 9079894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei.
    Moore RA; DeShazer D; Reckseidler S; Weissman A; Woods DE
    Antimicrob Agents Chemother; 1999 Mar; 43(3):465-70. PubMed ID: 10049252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence.
    DeShazer D; Brett PJ; Woods DE
    Mol Microbiol; 1998 Dec; 30(5):1081-100. PubMed ID: 9988483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei.
    Jones AL; DeShazer D; Woods DE
    Infect Immun; 1997 Dec; 65(12):4972-7. PubMed ID: 9393784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tn5-OT182 should not be used to identify genes involved in biofilm formation in Burkholderia pseudomallei.
    Songsri J; Proungvitaya T; Wongratanacheewin S; Homchampa P
    Southeast Asian J Trop Med Public Health; 2012 Jan; 43(1):124-8. PubMed ID: 23082562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans.
    Malott RJ; Steen-Kinnaird BR; Lee TD; Speert DP
    Antimicrob Agents Chemother; 2012 Jan; 56(1):464-71. PubMed ID: 22006009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyphosate resistance as a novel select-agent-compliant, non-antibiotic-selectable marker in chromosomal mutagenesis of the essential genes asd and dapB of Burkholderia pseudomallei.
    Norris MH; Kang Y; Lu D; Wilcox BA; Hoang TT
    Appl Environ Microbiol; 2009 Oct; 75(19):6062-75. PubMed ID: 19648360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis resistance to polymyxin B is determined by the lipid A 4'-phosphatase, PGN_0524.
    Coats SR; To TT; Jain S; Braham PH; Darveau RP
    Int J Oral Sci; 2009 Sep; 1(3):126-35. PubMed ID: 20657724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
    Sarovich DS; Price EP; Von Schulze AT; Cook JM; Mayo M; Watson LM; Richardson L; Seymour ML; Tuanyok A; Engelthaler DM; Pearson T; Peacock SJ; Currie BJ; Keim P; Wagner DM
    PLoS One; 2012; 7(2):e30789. PubMed ID: 22363490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei.
    Kanthawong S; Bolscher JG; Veerman EC; van Marle J; de Soet HJ; Nazmi K; Wongratanacheewin S; Taweechaisupapong S
    Int J Antimicrob Agents; 2012 Jan; 39(1):39-44. PubMed ID: 22005071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
    Mima T; Schweizer HP
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3113-20. PubMed ID: 20498323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved selective culture medium enhances the isolation of Burkholderia pseudomallei from contaminated specimens.
    Goodyear A; Strange L; Rholl DA; Silisouk J; Dance DAB; Schweizer HP; Dow S
    Am J Trop Med Hyg; 2013 Nov; 89(5):973-982. PubMed ID: 24062483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker.
    Zajdowicz SL; Jones-Carson J; Vazquez-Torres A; Jobling MG; Gill RE; Holmes RK
    PLoS One; 2011; 6(6):e21523. PubMed ID: 21720554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei.
    Hamad MA; Zajdowicz SL; Holmes RK; Voskuil MI
    Gene; 2009 Feb; 430(1-2):123-31. PubMed ID: 19010402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Burkholderia pseudomallei
    Mou S; Jenkins CC; Okaro U; Dhummakupt ES; Mach PM; DeShazer D
    Microbiol Spectr; 2021 Sep; 9(1):e0010221. PubMed ID: 34160272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid A Remodeling Is a Pathoadaptive Mechanism That Impacts Lipopolysaccharide Recognition and Intracellular Survival of Burkholderia pseudomallei.
    Norris MH; Somprasong N; Schweizer HP; Tuanyok A
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037795
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid A Modification and Metabolic Adaptation in Polymyxin-Resistant, New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae.
    Lu J; Han M; Yu HH; Bergen PJ; Liu Y; Zhao J; Wickremasinghe H; Jiang X; Hu Y; Du H; Zhu Y; Velkov T
    Microbiol Spectr; 2023 Aug; 11(4):e0085223. PubMed ID: 37432123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of the lipopolysaccharide deacylase PagL from latency compensates for a lack of lipopolysaccharide aminoarabinose modification-dependent resistance to the antimicrobial peptide polymyxin B in Salmonella enterica.
    Kawasaki K; China K; Nishijima M
    J Bacteriol; 2007 Jul; 189(13):4911-9. PubMed ID: 17483225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.